REGN SEC filings (2026)
CIK 872589 · Pharmaceutical Preparations (SIC 2834) · incorporated in NY · fiscal year ends in December
2,419 filings on EDGAR since 1995 · 34 annual, 91 quarterly, 305 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by the headline of the press release they furnish or by their items, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
October 2026
September 2026
- Sep 308-K8-K · Directors or officers; compensation
- Sep 3Insider saleMcCourt Marion (EVP Commercial) sold 1,131 shares for $970K at $857.39 under a 10b5-1 plan
- Sep 2Insider saleMcCourt Marion (EVP Commercial) sold 1,215 shares for $1.0M at $850.00 under a 10b5-1 plan
- Sep 2Insider saleGuarini Kathryn (Director) sold 400 shares for $340K at $850.00 under a 10b5-1 plan
August 2026
July 2026
- Jul 30EarningsEarnings release — EPS $12.53 vs $8.00 est. (+56.6%); revenue $4.29B (+17% y/y) 6.2%
- Jul 30ReportQuarterly report, Q2 2026 — revenue $4.29B (+17% y/y), net income $1.30B, EPS $12.23
- Jul 68-K8-K · Results of operations
- Jul 2Insider saleRYAN ARTHUR F (Director) sold 200 shares for $130K at $650.15 under a 10b5-1 plan
June 2026
- Jun 178-K8-K · Shareholder vote results
May 2026
April 2026
- Apr 29EarningsEarnings release — EPS $7.50 vs $6.28 est. (+19.4%); revenue $3.61B (+19% y/y) 6.2%
- Apr 29ReportQuarterly report, Q1 2026 — revenue $3.61B (+19% y/y), net income $727.2M, EPS $6.75
- Apr 24ProxyProxy · Annual report to shareholders
- Apr 24ProxyProxy · Additional proxy materials
- Apr 24ProxyProxy · Proxy statement
- Apr 88-K8-K · Results of operations
- Apr 1Insider saleRYAN ARTHUR F (Director) sold 100 shares for $78K at $771.32–$779.71 under a 10b5-1 plan
March 2026
February 2026
- Feb 19Insider saleZoghbi Huda Y (Director) sold 1,638 shares for $1.3M at $774.68–$790.00 under a 10b5-1 plan
- Feb 9Insider salePitofsky Jason (SVP Controller) sold 2,036 shares for $1.6M at $775.95–$785.72 under a 10b5-1 plan
- Feb 9Insider saleRYAN ARTHUR F (Director) sold 100 shares for $78K at $775.63–$787.82 under a 10b5-1 plan
- Feb 4ReportAnnual report, FY2025 — revenue $14.34B (+1% y/y), net income $4.50B, EPS $41.48
January 2026
October 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $11.0M in 14 sales and bought nothing on the open market; 49 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Oct 14, 2026Form 4 | MURPHY ANDREW JCo-Chief Scientific OfficerSold · $3.2M · 4,147 sh · 10b5-1 |
| Sep 3, 2026Form 4 | McCourt MarionEVP CommercialSold · $970K · 1,131 sh · 10b5-1 |
| Sep 2, 2026Form 4 | McCourt MarionEVP CommercialSold · $1.0M · 1,215 sh · 10b5-1 |
| Sep 2, 2026Form 4 | Guarini KathrynDirectorSold · $340K · 400 sh · 10b5-1 |
| Aug 10, 2026Form 4 | Zoghbi Huda YDirectorSold · $640K · 800 sh · 10b5-1 |
| Aug 10, 2026Form 4 | Guarini KathrynDirectorSold · $320K · 400 sh · 10b5-1 |
| Jul 2, 2026Form 4 | RYAN ARTHUR FDirectorSold · $130K · 200 sh · 10b5-1 |
| May 1, 2026Form 4 | RYAN ARTHUR FDirectorSold · $71K · 100 sh · 10b5-1 |
| Apr 1, 2026Form 4 | RYAN ARTHUR FDirectorSold · $78K · 100 sh · 10b5-1 |
| Mar 2, 2026Form 4 | RYAN ARTHUR FDirectorSold · $79K · 100 sh · 10b5-1 |
| Feb 19, 2026Form 4 | Zoghbi Huda YDirectorSold · $1.3M · 1,638 sh · 10b5-1 |
| Feb 9, 2026Form 4 | Pitofsky JasonSVP ControllerSold · $1.6M · 2,036 sh · 10b5-1 |
| Feb 9, 2026Form 4 | RYAN ARTHUR FDirectorSold · $78K · 100 sh · 10b5-1 |
| Jan 7, 2026Form 4 | Bassler Bonnie LDirectorSold · $1.2M · 1,500 sh · 10b5-1 |
Awards, exercises, withholding and plan purchases · 49 transactions
| Date | Insider |
|---|---|
| Oct 13, 2026Form 4 | MURPHY ANDREW JCo-Chief Scientific OfficerTax withholding · $9.7M · 12,853 sh · 10b5-1 |
| Oct 13, 2026Form 4 | MURPHY ANDREW JCo-Chief Scientific OfficerExercise or conversion · $6.5M · 17,000 sh · 10b5-1 |
| Oct 13, 2026Form 4 | MURPHY ANDREW JCo-Chief Scientific OfficerExercise or conversion · Non-Qualified Stock Option… · $0 · 17,000 sh · 10b5-1 |
| Sep 2, 2026Form 4 | Guarini KathrynDirectorExercise or conversion · $288K · 400 sh · 10b5-1 |
| Sep 2, 2026Form 4 | Guarini KathrynDirectorExercise or conversion · Non-Qualified Stock Option… · $0 · 400 sh · 10b5-1 |
| Aug 19, 2026Form 4 | LAROSA JOSEPH JEVP General Counsel and SecretTax withholding · $7.5M · 9,019 sh |
| Aug 19, 2026Form 4 | LAROSA JOSEPH JEVP General Counsel and SecretExercise or conversion · $4.7M · 12,282 sh |
| Aug 19, 2026Form 4 | LAROSA JOSEPH JEVP General Counsel and SecretExercise or conversion · Non-Qualified Stock Option… · $0 · 12,282 sh |
| Aug 18, 2026Form 4 | Fenimore Christopher R.EVP Finance CFOTax withholding · $3.7M · 4,599 sh |
| Aug 18, 2026Form 4 | Fenimore Christopher R.EVP Finance CFOExercise or conversion · $2.4M · 6,283 sh |
| Aug 18, 2026Form 4 | Fenimore Christopher R.EVP Finance CFOExercise or conversion · Non-Qualified Stock Option… · $0 · 6,283 sh |
| Aug 10, 2026Form 4 | Zoghbi Huda YDirectorExercise or conversion · $301K · 800 sh · 10b5-1 |
| Aug 10, 2026Form 4 | Guarini KathrynDirectorExercise or conversion · $288K · 400 sh · 10b5-1 |
| Aug 10, 2026Form 4 | Zoghbi Huda YDirectorExercise or conversion · Non-Qualified Stock Option… · $0 · 800 sh · 10b5-1 |
| Aug 10, 2026Form 4 | Guarini KathrynDirectorExercise or conversion · Non-Qualified Stock Option… · $0 · 400 sh · 10b5-1 |
| Feb 19, 2026Form 4 | Zoghbi Huda YDirectorExercise or conversion · $617K · 1,638 sh · 10b5-1 |
| Feb 19, 2026Form 4 | Zoghbi Huda YDirectorExercise or conversion · Non-Qualified Stock Option… · $0 · 1,638 sh · 10b5-1 |
| Feb 9, 2026Form 4 | Pitofsky JasonSVP ControllerExercise or conversion · $492K · 1,000 sh · 10b5-1 |
| Feb 9, 2026Form 4 | Pitofsky JasonSVP ControllerExercise or conversion · Non-Qualified Stock Option… · $0 · 1,000 sh · 10b5-1 |
| Jan 7, 2026Form 4 | Bassler Bonnie LDirectorExercise or conversion · $561K · 1,500 sh · 10b5-1 |
| Jan 7, 2026Form 4 | Bassler Bonnie LDirectorExercise or conversion · Non-Qualified Stock Option… · $0 · 1,500 sh · 10b5-1 |
| Jan 2, 2026Form 4 | BROWN MICHAEL SDirectorAward · Non-Qualified Stock Option… · $0 · 1,962 sh |
| Jan 2, 2026Form 4 | RYAN ARTHUR FDirectorAward · Non-Qualified Stock Option… · $0 · 1,962 sh |
| Jan 2, 2026Form 4 | POON CHRISTINE ADirectorAward · Non-Qualified Stock Option… · $0 · 1,962 sh |
| Jan 2, 2026Form 4 | COLES N ANTHONYDirectorAward · Non-Qualified Stock Option… · $0 · 1,962 sh |
| Jan 2, 2026Form 4 | SING GEORGE LDirectorAward · Non-Qualified Stock Option… · $0 · 1,962 sh |
| Jan 2, 2026Form 4 | GOLDSTEIN JOSEPH LDirectorAward · Non-Qualified Stock Option… · $0 · 1,962 sh |
| Jan 2, 2026Form 4 | Thompson Craig B.DirectorAward · Non-Qualified Stock Option… · $0 · 1,962 sh |
| Jan 2, 2026Form 4 | Schenkein David PDirectorAward · Non-Qualified Stock Option… · $0 · 1,962 sh |
| Jan 2, 2026Form 4 | Zoghbi Huda YDirectorAward · Non-Qualified Stock Option… · $0 · 1,962 sh |
| Jan 2, 2026Form 4 | Bassler Bonnie LDirectorAward · Non-Qualified Stock Option… · $0 · 1,962 sh |
| Jan 2, 2026Form 4 | Guarini KathrynDirectorAward · Non-Qualified Stock Option… · $0 · 1,962 sh |
| Jan 2, 2026Form 4 | BROWN MICHAEL SDirectorAward · $0 · 155 sh |
| Jan 2, 2026Form 4 | RYAN ARTHUR FDirectorAward · $0 · 155 sh |
| Jan 2, 2026Form 4 | POON CHRISTINE ADirectorAward · $0 · 155 sh |
| Jan 2, 2026Form 4 | COLES N ANTHONYDirectorAward · $0 · 155 sh |
| Jan 2, 2026Form 4 | SING GEORGE LDirectorAward · $0 · 155 sh |
| Jan 2, 2026Form 4 | GOLDSTEIN JOSEPH LDirectorAward · $0 · 155 sh |
| Jan 2, 2026Form 4 | Thompson Craig B.DirectorAward · $0 · 155 sh |
| Jan 2, 2026Form 4 | Schenkein David PDirectorAward · $0 · 155 sh |
| Jan 2, 2026Form 4 | Zoghbi Huda YDirectorAward · $0 · 155 sh |
| Jan 2, 2026Form 4 | Bassler Bonnie LDirectorAward · $0 · 155 sh |
| Jan 2, 2026Form 4 | Guarini KathrynDirectorAward · $0 · 155 sh |
| Dec 31, 2025Form 4 | SCHLEIFER LEONARD SBd. Co-Chair, President & CEO · DirectorTax withholding · $22.1M · 28,570 sh |
| Dec 31, 2025Form 4 | YANCOPOULOS GEORGEBd. Co-Chair, President & CSO · DirectorTax withholding · $22.1M · 28,570 sh |
| Dec 31, 2025Form 4 | SCHLEIFER LEONARD SBd. Co-Chair, President & CEO · DirectorExercise or conversion · $0 · 28,570 sh |
| Dec 31, 2025Form 4 | SCHLEIFER LEONARD SBd. Co-Chair, President & CEO · DirectorExercise or conversion · 2020 Performance Stock Units · $0 · 28,570 sh |
| Dec 31, 2025Form 4 | YANCOPOULOS GEORGEBd. Co-Chair, President & CSO · DirectorExercise or conversion · $0 · 28,570 sh |
| Dec 31, 2025Form 4 | YANCOPOULOS GEORGEBd. Co-Chair, President & CSO · DirectorExercise or conversion · 2020 Performance Stock Units · $0 · 28,570 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K that furnishes a press release is headed by the release’s headline, its items beneath; any other 8-K is described by its items. A form opens the press release where there is one, else the document on EDGAR, or the filing’s index where it furnishes other exhibits.
2026 · 15 filings
| Filed | What it is |
|---|---|
| Oct 6, 20268-K | Material definitive agreement; Results of operations; Other events |
| Sep 30, 20268-K | Directors or officers; compensation |
| Jul 30, 202610-Q | Quarterly report, Q2 2026 — revenue $4.29B (+17% y/y), net income $1.30B, EPS $12.23 |
| Jul 30, 20268-K | Earnings release — EPS $12.53 vs $8.00 est. (+56.6%); revenue $4.29B (+17% y/y) 6.2% |
| Jul 6, 20268-K | Results of operations |
| Jun 17, 20268-K | Shareholder vote results |
| Apr 29, 202610-Q | Quarterly report, Q1 2026 — revenue $3.61B (+19% y/y), net income $727.2M, EPS $6.75 |
| Apr 29, 20268-K | Earnings release — EPS $7.50 vs $6.28 est. (+19.4%); revenue $3.61B (+19% y/y) 6.2% |
| Apr 24, 2026ARS | Annual report to shareholders |
| Apr 24, 2026DEFA14A | Additional proxy materials |
| Apr 24, 2026DEF 14A | Proxy statement |
| Apr 8, 20268-K | Results of operations |
| Feb 4, 202610-K | Annual report, FY2025 — revenue $14.34B (+1% y/y), net income $4.50B, EPS $41.48 |
| Jan 30, 20268-K | Earnings release — EPS $9.90 vs $8.28 est. (+12.3%); revenue $3.88B (+3% y/y) 1.1% |
| Jan 12, 20268-K | Results of operations; Regulation FD disclosure |
2025 · 15 filings
| Filed | What it is |
|---|---|
| Oct 28, 202510-Q | Quarterly report, Q3 2025 — revenue $3.75B (+1% y/y), net income $1.46B, EPS $13.62 |
| Oct 28, 20258-K | Earnings release — EPS $9.63 vs $7.52 est. (+28.1%); revenue $3.75B (+1% y/y) 11.8% |
| Oct 6, 20258-K | Results of operations |
| Aug 1, 202510-Q | Quarterly report, Q2 2025 — revenue $3.68B (+4% y/y), net income $1.39B, EPS $12.81 |
| Aug 1, 20258-K | Earnings release — EPS $10.72 vs $6.09 est. (+76.0%); revenue $3.68B (+4% y/y) 2.5% |
| Jun 18, 20258-K | Shareholder vote results |
| Apr 29, 202510-Q | Quarterly report, Q1 2025 — revenue $3.03B (−4% y/y), net income $808.7M, EPS $7.27 |
| Apr 29, 20258-K | Earnings release — EPS $6.43 vs $6.61 est. (−2.7%); revenue $3.03B (−4% y/y) 6.9% |
| Apr 29, 2025ARS | Annual report to shareholders |
| Apr 29, 2025DEFA14A | Additional proxy materials |
| Apr 29, 2025DEF 14A | Proxy statement |
| Apr 7, 2025PRE 14A | Preliminary proxy statement |
| Feb 5, 202510-K | Annual report, FY2024 — revenue $14.20B (+8% y/y), net income $4.41B, EPS $38.34 |
| Feb 4, 20258-K | Earnings release — EPS $9.90 vs $9.62 est. (+2.9%); revenue $3.79B (+10% y/y) 4.5% |
| Jan 13, 20258-K | Results of operations; Regulation FD disclosure |
2024 · 16 filings
| Filed | What it is |
|---|---|
| Oct 31, 202410-Q | Quarterly report, Q3 2024 — revenue $3.72B (+11% y/y), net income $1.34B, EPS $11.54 |
| Oct 31, 20248-K | Earnings release — EPS $11.73 vs $10.06 est. (+16.6%); revenue $3.72B (+11% y/y) 9.2% |
| Oct 7, 20248-K | Results of operations |
| Aug 1, 202410-Q | Quarterly report, Q2 2024 — revenue $3.55B (+12% y/y), net income $1.43B, EPS $12.41 |
| Aug 1, 20248-K | Earnings release — EPS $10.10 vs $8.93 est. (+13.1%); revenue $3.55B (+12% y/y) 1.3% |
| Jul 8, 20248-K | Results of operations |
| Jun 20, 20248-K | Shareholder vote results |
| May 2, 202410-Q | Quarterly report, Q1 2024 — revenue $3.15B (−1% y/y), net income $722.0M, EPS $6.27 |
| May 2, 20248-K | Earnings release — EPS $7.97 vs $8.46 est. (−5.8%); revenue $3.15B (−1% y/y) 3.8% |
| Apr 25, 2024ARS | Annual report to shareholders |
| Apr 25, 2024DEFA14A | Additional proxy materials |
| Apr 25, 2024DEF 14A | Proxy statement |
| Feb 5, 202410-K | Annual report, FY2023 — revenue $13.12B (+8% y/y), net income $3.95B, EPS $34.77 |
| Feb 2, 20248-K | Earnings release — EPS $10.18 vs $9.10 est. (+11.9%); revenue $3.43B (+1% y/y) 1.3% |
| Jan 31, 20248-K | Directors or officers; compensation |
| Jan 8, 20248-K | Results of operations; Regulation FD disclosure |
2023 · 21 filings — 11 × 8-K, 3 × 10-Q, 2 × DEFA14A and 5 other forms
| Filed | What it is |
|---|---|
| Nov 2, 202310-Q | Quarterly report, Q3 2023 — revenue $3.36B (+15% y/y), net income $1.01B, EPS $8.89 |
| Aug 3, 202310-Q | Quarterly report, Q2 2023 — revenue $3.16B (+11% y/y), net income $968.4M, EPS $8.50 |
| May 18, 2023PX14A6G | Shareholder exempt solicitation |
| May 17, 2023DEFA14A | Additional proxy materials |
| May 4, 202310-Q | Quarterly report, Q1 2023 — revenue $3.16B (+7% y/y), net income $817.8M, EPS $7.17 |
| Apr 21, 2023ARS | Annual report to shareholders |
| Apr 21, 2023DEFA14A | Additional proxy materials |
| Apr 21, 2023DEF 14A | Proxy statement |
| Feb 6, 202310-K | Annual report, FY2022 — revenue $12.17B (−24% y/y), net income $4.34B, EPS $38.22 |
12 current reports (8-K) not listed; the year is on EDGAR.
2022 · 17 filings — 10 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms
| Filed | What it is |
|---|---|
| Nov 3, 202210-Q | Quarterly report, Q3 2022 — revenue $2.94B (−15% y/y), net income $1.32B, EPS $11.66 |
| Aug 3, 202210-Q | Quarterly report, Q2 2022 — revenue $2.86B (−44% y/y), net income $852.1M, EPS $7.47 |
| May 4, 202210-Q | Quarterly report, Q1 2022 — revenue $2.97B (+17% y/y), net income $973.5M, EPS $8.61 |
| Apr 21, 2022DEFA14A | Additional proxy materials |
| Apr 21, 2022DEFA14A | Additional proxy materials |
| Apr 21, 2022DEF 14A | Proxy statement |
| Feb 7, 202210-K | Annual report, FY2021 — revenue $16.07B (+89% y/y), net income $8.08B, EPS $71.97 |
10 current reports (8-K) not listed; the year is on EDGAR.
2021 · 17 filings — 9 × 8-K, 3 × 10-Q, 3 × DEFA14A and 2 other forms
| Filed | What it is |
|---|---|
| Nov 4, 202110-Q | Quarterly report, Q3 2021 — revenue $3.45B (+51% y/y), net income $1.63B, EPS $14.33 |
| Aug 5, 202110-Q | Quarterly report, Q2 2021 — revenue $5.14B (+163% y/y), net income $3.10B, EPS $27.97 |
| May 6, 202110-Q | Quarterly report, Q1 2021 — revenue $2.53B (+38% y/y), net income $1.12B, EPS $10.09 |
| May 3, 2021DEFA14A | Additional proxy materials |
| Apr 23, 2021DEFA14A | Additional proxy materials |
| Apr 23, 2021DEFA14A | Additional proxy materials |
| Apr 23, 2021DEF 14A | Proxy statement |
| Feb 8, 202110-K | Annual report, FY2020 — revenue $8.50B (+30% y/y), net income $3.51B, EPS $30.52 |
9 current reports (8-K) not listed; the year is on EDGAR.
2020 · 19 filings — 11 × 8-K, 3 × 10-Q, 3 × DEFA14A and 2 other forms
| Filed | What it is |
|---|---|
| Nov 5, 202010-Q | Quarterly report, Q3 2020 — revenue $2.29B (+32% y/y), net income $842.1M, EPS $7.39 |
| Aug 5, 202010-Q | Quarterly report, Q2 2020 — revenue $1.95B (+24% y/y), net income $897.3M, EPS $7.61 |
| Jun 8, 2020DEFA14A | Additional proxy materials |
| May 5, 202010-Q | Quarterly report, Q1 2020 — revenue $1.83B (+33% y/y), net income $624.6M, EPS $5.43 |
| Apr 24, 2020DEFA14A | Additional proxy materials |
| Apr 24, 2020DEFA14A | Additional proxy materials |
| Apr 24, 2020DEF 14A | Proxy statement |
| Feb 7, 202010-K | Annual report, FY2019 — revenue $6.56B (+27% y/y), net income $2.12B, EPS $18.46 |
11 current reports (8-K) not listed; the year is on EDGAR.
2019 · 16 filings — 8 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Nov 5, 201910-Q | Quarterly report, Q3 2019 — revenue $1.74B (+5% y/y), net income $669.6M, EPS $5.86 |
| Aug 6, 201910-Q | Quarterly report, Q2 2019 — revenue $1.58B (−2% y/y), net income $193.1M, EPS $1.68 |
| May 7, 201910-Q | Quarterly report, Q1 2019 — revenue $1.37B (−9% y/y), net income $461.1M, EPS $3.99 |
| Apr 26, 2019DEFA14A | Additional proxy materials |
| Apr 26, 2019DEFA14A | Additional proxy materials |
| Apr 26, 2019DEF 14A | Proxy statement |
| Feb 7, 201910-K | Annual report, FY2018 — revenue $5.15B (−12% y/y), net income $2.44B, EPS $21.29 |
9 current reports (8-K) not listed; the year is on EDGAR.
2018 · 17 filings — 10 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms
| Filed | What it is |
|---|---|
| Nov 6, 201810-Q | Quarterly report, Q3 2018 — revenue $1.66B (+11% y/y), net income $594.7M, EPS $5.17 |
| Aug 2, 201810-Q | Quarterly report, Q2 2018 — revenue $1.61B (+9% y/y), net income $551.4M, EPS $4.82 |
| May 3, 201810-Q | Quarterly report, Q1 2018 — revenue $1.51B (+15% y/y), net income $478.0M, EPS $4.16 |
| Apr 23, 2018DEFA14A | Additional proxy materials |
| Apr 23, 2018DEFA14A | Additional proxy materials |
| Apr 23, 2018DEF 14A | Proxy statement |
| Feb 8, 201810-K | Annual report, FY2017 — revenue $5.87B (+21% y/y), net income $1.20B, EPS $10.34 |
10 current reports (8-K) not listed; the year is on EDGAR.
2017 · 17 filings — 9 × 8-K, 3 × 10-Q, 2 × DEFA14A and 3 other forms
| Filed | What it is |
|---|---|
| Nov 8, 201710-Q | Quarterly report, Q3 2017 — revenue $1.50B (+23% y/y), net income $388.3M, EPS $3.32 |
| Aug 3, 201710-Q | Quarterly report, Q2 2017 — revenue $1.47B (+21% y/y), net income $387.7M, EPS $3.34 |
| May 4, 201710-Q | Quarterly report, Q1 2017 — revenue $1.32B (+10% y/y), net income $248.9M, EPS $2.16 |
| Apr 25, 2017DEFA14A | Additional proxy materials |
| Apr 25, 2017DEFA14A | Additional proxy materials |
| Apr 25, 2017DEF 14A | Proxy statement |
| Feb 9, 201710-K | Annual report, FY2016 — revenue $4.86B (+18% y/y), net income $895.5M, EPS $7.70 |
10 current reports (8-K) not listed; the year is on EDGAR.
2016 · 25 filings — 18 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms
Counted, not listed; the year is on EDGAR.
2015 · 24 filings — 16 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2014 · 22 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2013 · 18 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2012 · 15 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2011 · 35 filings — 24 × 8-K, 3 × 10-Q, 3 × DEFA14A and 4 other forms
Counted, not listed; the year is on EDGAR.
2010 · 21 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2009 · 16 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2008 · 18 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2007 · 20 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2006 · 24 filings — 18 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2005 · 20 filings — 14 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2004 · 21 filings — 11 × 8-K, 3 × 10-Q, 2 × 10-K/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2003 · 14 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2002 · 8 filings — 3 × 10-Q, 3 × 8-K, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2001 · 9 filings — 3 × 10-Q, 3 × 8-K, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2000 · 7 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
1999 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A and 1 other form
Counted, not listed; the year is on EDGAR.
1998 · 5 filings — 3 × 10-Q, 1 × 10-K, 1 × DEF 14A
Counted, not listed; the year is on EDGAR.
1997 · 8 filings — 3 × 10-Q, 2 × 8-K, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
1996 · 2 filings — 2 × 10-Q
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 45 filings — 28 × 4, 11 × 144, 3 × 13F-HR and 3 other forms
| Filed | What it is |
|---|---|
| Oct 15, 20264 | Insider transaction (Form 4) |
| Oct 14, 2026144 | Notice of proposed sale (Form 144) |
| Sep 3, 20264 | Insider transaction (Form 4) |
| Sep 3, 20264 | Insider transaction (Form 4) |
| Sep 3, 2026144 | Notice of proposed sale (Form 144) |
| Sep 2, 2026144 | Notice of proposed sale (Form 144) |
| Sep 2, 2026144 | Notice of proposed sale (Form 144) |
| Aug 21, 20264 | Insider transaction (Form 4) |
| Aug 20, 2026N-PX | Other filings |
| Aug 20, 20264 | Insider transaction (Form 4) |
| Aug 12, 20264 | Insider transaction (Form 4) |
| Aug 12, 20264 | Insider transaction (Form 4) |
| Aug 10, 2026144 | Notice of proposed sale (Form 144) |
| Aug 10, 2026144 | Notice of proposed sale (Form 144) |
| Aug 7, 202613F-HR | Other filings |
| Jul 7, 20264 | Insider transaction (Form 4) |
| Jul 2, 2026144 | Notice of proposed sale (Form 144) |
| May 8, 202613F-HR | Other filings |
| May 4, 20264 | Insider transaction (Form 4) |
| Apr 30, 2026SCHEDULE 13G | Other filings |
| Apr 3, 20264 | Insider transaction (Form 4) |
| Mar 27, 2026SCHEDULE 13G/A | Other filings |
| Mar 3, 20264 | Insider transaction (Form 4) |
| Feb 23, 20264 | Insider transaction (Form 4) |
| Feb 19, 2026144 | Notice of proposed sale (Form 144) |
The newest 25 of 45 shown; the full year is on EDGAR.
2025 · 42 filings — 28 × 4, 4 × 13F-HR, 4 × SCHEDULE 13G/A and 3 other forms
| Filed | What it is |
|---|---|
| Dec 31, 20254 | Insider transaction (Form 4) |
| Dec 11, 20254 | Insider transaction (Form 4) |
| Dec 11, 20254 | Insider transaction (Form 4) |
| Dec 11, 20254 | Insider transaction (Form 4) |
| Dec 11, 20254 | Insider transaction (Form 4) |
| Dec 11, 20254 | Insider transaction (Form 4) |
| Dec 9, 20254 | Insider transaction (Form 4) |
| Dec 9, 20254 | Insider transaction (Form 4) |
| Dec 9, 20254 | Insider transaction (Form 4) |
| Dec 9, 20254 | Insider transaction (Form 4) |
| Dec 9, 20254 | Insider transaction (Form 4) |
| Dec 9, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 24, 20254 | Insider transaction (Form 4) |
| Nov 20, 2025144 | Notice of proposed sale (Form 144) |
| Nov 10, 20254 | Insider transaction (Form 4) |
| Nov 7, 2025144 | Notice of proposed sale (Form 144) |
| Nov 7, 202513F-HR | Other filings |
| Oct 31, 20254 | Insider transaction (Form 4) |
| Oct 31, 20254 | Insider transaction (Form 4) |
| Oct 29, 2025144 | Notice of proposed sale (Form 144) |
| Aug 6, 2025SCHEDULE 13G/A | Other filings |
| Aug 1, 202513F-HR | Other filings |
| Jun 5, 2025SCHEDULE 13G/A | Other filings |
| May 2, 202513F-HR | Other filings |
The newest 25 of 42 shown; the full year is on EDGAR.
2024 · 168 filings — 104 × 4, 51 × 144, 6 × SC 13G/A and 4 other forms
| Filed | What it is |
|---|---|
| Dec 18, 20244 | Insider transaction (Form 4) |
| Dec 18, 20244 | Insider transaction (Form 4) |
| Dec 18, 20244 | Insider transaction (Form 4) |
| Dec 18, 20244 | Insider transaction (Form 4) |
| Dec 18, 20244 | Insider transaction (Form 4) |
| Dec 18, 20244 | Insider transaction (Form 4) |
| Dec 18, 20244 | Insider transaction (Form 4) |
| Dec 10, 20244 | Insider transaction (Form 4) |
| Dec 10, 20244 | Insider transaction (Form 4) |
| Dec 10, 20244 | Insider transaction (Form 4) |
| Dec 10, 20244 | Insider transaction (Form 4) |
| Dec 10, 20244 | Insider transaction (Form 4) |
| Dec 10, 20244 | Insider transaction (Form 4) |
| Dec 10, 20244 | Insider transaction (Form 4) |
| Nov 12, 20244 | Insider transaction (Form 4) |
| Nov 5, 20244 | Insider transaction (Form 4) |
| Nov 1, 2024144 | Notice of proposed sale (Form 144) |
| Oct 31, 2024S-3ASR | Automatic shelf registration |
| Oct 3, 20244 | Insider transaction (Form 4) |
| Oct 3, 20244 | Insider transaction (Form 4) |
| Oct 1, 2024144 | Notice of proposed sale (Form 144) |
| Sep 11, 2024UPLOAD | Letter from the SEC staff |
| Sep 5, 20244 | Insider transaction (Form 4) |
| Sep 5, 20244 | Insider transaction (Form 4) |
| Sep 5, 20244 | Insider transaction (Form 4) |
The newest 25 of 168 shown; the full year is on EDGAR.
2023 · 120 filings — 83 × 4, 23 × 144, 4 × SC 13G/A and 7 other forms
Counted, not listed; the year is on EDGAR.
2022 · 110 filings — 93 × 4, 7 × SC 13G/A, 3 × SC TO-T/A and 6 other forms
Counted, not listed; the year is on EDGAR.
2021 · 97 filings — 89 × 4, 4 × SC 13G/A, 1 × 3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2020 · 128 filings — 110 × 4, 4 × SC 13G/A, 3 × 424B3 and 8 other forms
Counted, not listed; the year is on EDGAR.
2019 · 47 filings — 38 × 4, 3 × CT ORDER, 3 × SC 13G/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2018 · 53 filings — 41 × 4, 4 × SC 13G/A, 2 × 5 and 5 other forms
Counted, not listed; the year is on EDGAR.
2017 · 56 filings — 44 × 4, 4 × CT ORDER, 3 × SC 13G/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2016 · 53 filings — 31 × 4, 6 × CORRESP, 5 × SC 13G/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2015 · 83 filings — 71 × 4, 4 × SC 13G/A, 3 × CT ORDER and 3 other forms
Counted, not listed; the year is on EDGAR.
2014 · 102 filings — 84 × 4, 4 × SC 13G/A, 3 × CORRESP and 7 other forms
Counted, not listed; the year is on EDGAR.
2013 · 93 filings — 78 × 4, 7 × SC 13G/A, 2 × UPLOAD and 6 other forms
Counted, not listed; the year is on EDGAR.
2012 · 106 filings — 97 × 4, 5 × SC 13G/A, 2 × CT ORDER and 2 other forms
Counted, not listed; the year is on EDGAR.
2011 · 95 filings — 87 × 4, 4 × SC 13G/A, 2 × 3 and 2 other forms
Counted, not listed; the year is on EDGAR.
2010 · 74 filings — 55 × 4, 4 × SC 13G/A, 3 × 4/A and 7 other forms
Counted, not listed; the year is on EDGAR.
2009 · 49 filings — 35 × 4, 6 × SC 13G/A, 3 × UPLOAD and 4 other forms
Counted, not listed; the year is on EDGAR.
2008 · 52 filings — 41 × 4, 4 × SC 13G/A, 3 × CT ORDER and 2 other forms
Counted, not listed; the year is on EDGAR.
2007 · 59 filings — 43 × 4, 4 × 3, 4 × SC 13G/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2006 · 63 filings — 51 × 4, 5 × SC 13G/A, 2 × SC 13G and 5 other forms
Counted, not listed; the year is on EDGAR.
2005 · 57 filings — 42 × 4, 6 × SC 13G/A, 3 × SC 13G and 4 other forms
Counted, not listed; the year is on EDGAR.
2004 · 56 filings — 38 × 4, 5 × SC 13G/A, 2 × 424B3 and 8 other forms
Counted, not listed; the year is on EDGAR.
2003 · 43 filings — 28 × 4, 10 × SC 13G/A, 2 × SC 13G and 3 other forms
Counted, not listed; the year is on EDGAR.
2002 · 16 filings — 7 × 424B3, 3 × SC 13G/A, 2 × S-3/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2001 · 21 filings — 4 × S-3/A, 4 × SC 13D/A, 4 × SC 13G and 8 other forms
Counted, not listed; the year is on EDGAR.
2000 · 8 filings — 4 × SC 13D/A, 1 × 424B1, 1 × S-3 and 2 other forms
Counted, not listed; the year is on EDGAR.
1999 · 3 filings — 1 × S-8, 1 × SC 13G, 1 × SC 13G/A
Counted, not listed; the year is on EDGAR.
1998 · 1 filing — 1 × SC 13G
Counted, not listed; the year is on EDGAR.
1997 · 4 filings — 1 × S-8, 1 × SC 13D, 1 × SC 13D/A and 1 other form
Counted, not listed; the year is on EDGAR.
1996 · 4 filings — 2 × SC 13D/A, 1 × 8-A12G, 1 × DEFN14A
Counted, not listed; the year is on EDGAR.
1995 · 3 filings — 2 × SC 13D/A, 1 × SC 13D
Counted, not listed; the year is on EDGAR.
About this data#
Regeneron Pharmaceuticals Inc. (REGN) has 2,419 filings on EDGAR going back to 1995: 34 annual reports, 91 quarterly reports and 305 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 4, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Oct 6, 2026, covered material definitive agreement; results of operations; other events. Over the last 13 months insiders sold $11.0M in 14 sales and bought nothing on the open market; 49 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Regeneron Pharmaceuticals Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read REGN's latest 10-K?
- REGN's latest annual report, a 10-K, was filed on Feb 4, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did REGN last file an 8-K?
- On Oct 6, 2026 it covered material definitive agreement; results of operations; other events. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Oct 6, 2026.
- Are REGN insiders buying or selling?
- Over the last 13 months insiders sold $11.0M in 14 sales and bought nothing on the open market; 49 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: MURPHY ANDREW J (Co-Chief Scientific Officer) sold 4,147 shares on Oct 14, 2026 for $3.2M, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has REGN made?
- 2,419 filings are on EDGAR under the registrant records that have been Regeneron Pharmaceuticals Inc., going back to 1995; 1,570 of them are insider ownership forms (Forms 3, 4, 5 and 144).